SUMMARY
- Deep-tech startup Nexstem secures $3.5 million to scale its BCI ecosystem and expand its intellectual property portfolio.
- Funds will accelerate the deployment of its AI-powered Brain-Computer Interface (BCI) suite, Instinct, and enhance biosignal infrastructure.
- The company’s innovative BCI solutions are designed to support researchers, clinicians, and developers in advancing brain-computer interactions.
Nexstem, a Bengaluru-based deep-tech startup specializing in Brain-Computer Interface (BCI) technology, has raised $3.5 million in its latest funding round. The round was co-led by prominent investors InfoEdge, Zupee, Smile Group, and Gruhas, founded by Nikhil Kamath and Abhijeet Pai.
The funding will be directed towards scaling Nexstem’s innovative product ecosystem, expanding its intellectual property portfolio, and accelerating the deployment of its AI-powered BCI suite, Instinct. The company’s focus is on advancing biosignal infrastructure and making BCI technology more accessible to researchers, clinicians, and developers globally.
Founded in 2020 by Siddhanth and Deepansh, Nexstem has developed Instinct, a cutting-edge BCI product suite designed as a development kit (devkit) to aid researchers in overcoming the complexities of implementing and refining proof-of-concept (POC) use cases in BCI technology. Instinct is powered by AI and offers a comprehensive end-to-end platform that integrates hardware, SDKs, APIs, and real-time biosignal algorithms.
This breakthrough technology has already garnered attention from industry giants, including Microsoft for Startups, NASSCOM, and VIVA Tech Paris. Nexstem’s non-invasive BCI solutions promise to revolutionize brain-computer interaction, allowing direct communication between the human brain and external devices.
The raised capital will enable Nexstem to continue innovating and expanding its product offerings, ensuring the startup plays a pivotal role in the future of deep-tech BCI solutions.
